Ruboxistaurin is a macrocyclic bisindolylmaleimide compound under development by Eli Lilly with potential as a therapy for diabetic macular oedema and other diabetic angiopathies, including diabetic retinopathy, diabetic peripheral neuropathy and diabetic. It is an investigational drug. Reference standards of Ruboxistaurin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Ruboxistaurin-d6 Hydrochloride [catalogue_number] => PA STI 078550 [category_ids] => ,79,71,81,98,78,70,82, [chemical_name] => [weight] => 511.04 [form] => C28H23D6ClN4O3 [cas] => 1794767-04-6 [pslug] => 1794767-04-6-ruboxistaurin-d6-hydrochloride-pasti078550 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA STI 078550
CAS :
Molecular Formula : C28H23D6ClN4O3
Molecular Weight : 511.04
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
